Reversible reproductive control in harbour seals (Phoca vitulina) with a gonadotropin-releasing hormone agonist.
Reproductive control in captive pinnipeds is an important management subject for many facilities. To date reproductive control in harbour seals (Phoca vitulina) has been achieved using anti-androgens, progestagen preparations, castration, and physical separation of the sexes. The harbour seal group at the seal station in Friedrichskoog, Germany consists of three mature females (all >10 years), one older mature male (13 years of age in 2000) and one male who reached maturity during the study (3 years of age in 2000). In 2000 the older mature male received for the first time a 3-month depot injection of a gonadotropin-releasing hormone agonist (buserelin acetetate, 9.9 mg) by subcutaneous injection. This male was subsequently given the gonadotropin-releasing hormone agonist in 2001, 2004 and 2005. The younger male reached maturity during the investigation and received burserelin for the first time in 2004 and again in 2005. No pups were born in 2001, 2002, 2005 or 2006. No reproductive control was performed in 2002 and 2003, resulting in three newborns in 2003 and 2004. Serum levels of testosterone were measured by a routine liquid chromatography coupled with mass spectometry. Pre-burserelin testosterone levels varied between 0.02 and 2.18 ng/ml. Post-burserelin levels were under the detection limit except for the first year of the investigation. No behavioural changes such as changes in social ranking and no clinical side effects were observed. This study shows that the gonadotropin-releasing hormone agonist, burserelin acetate, can be used for reversible reproductive control in harbour seals without observed side effects or detrimental behavioural changes.
Siebert
U
U
Research and Technology Center Westcoast, University of Kiel, Werftstrasse 6, 25761 Büsum, Germany. ursula.siebert@ftz-west.uni-kiel.de
Driver
J
J
Rosenberger
T
T
Atkinson
S
S
D000818:Animals; D002064:Buserelin / Q000008:administration & dosage / Q000494:pharmacology*; D003267:Contraception / Q000662:veterinary*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D046049:Phoca / Q000502:physiology*; D011247:Pregnancy; D012098:Reproduction / Q000187:drug effects*; D012726:Sexual Behavior, Animal / Q000187:drug effects; D013739:Testosterone / Q000097:blood; D013997:Time Factors
D005300:Fertility Agents, Female; D013739:Testosterone; D002064:Buserelin